NZ228593A - Process for the preparation of magnetically influenced homeopathic formulations - Google Patents

Description

22 8 5 9 3 Priority Date{s):..J..'7..1\ Complete Specification Fiiecl: Class: Publication Date: P.O. Journal, No: ,— r Patents form No 5 Number PATENTS ACT 19S3 Dated S *•' COMPLETE SPECIFICATION ! V MAGNETICALLY INFLUENCED HOMEOPATHIC PHARMACEUTICAL FORMULATIONS, METHODS OF THEIR PREPARATION AND METHODS OF THEIR ADMINISTRATION |/W€X WALTER WHITSON-FISCHMAN, 325 East 65th Street, New York, New York, 10-021 , United States of America, a citizen of United States of America do hereby declare the invention for which 1/iOe pray that a Patent may be granted to me&w, and the method by which it is to be performed, to be particularly described in and by the following statement: 22 85 9 FIELD OF THE INVENTION This invention relates to horneopathic medicaments and methods for the treatment of illness and injury in human beings usino such homeopathic medicaments.

More particularly, the invention relates to homeopathic methods of treatment of conditions including illnesses, pathogenic diseases, allergies, chemical and hormonal imbalances, addictive chemical dependencies, and physical injuries to the human body. The methods of treatment include oral, topical, auricular and injectable forms of homeopathic formulations which are magnetically treated or influenced during administeration to a patient through specific acupuncture points.

BACKGFOUNP OF THE INVENTION Homeopathy is an ancient healing art and forms a vital part of medical therapy. The practice of homeopathy is widespread, particularly in eastern cultures and many European countries. Homeopathic medicine teaches the use of natural based remedies and, as such, provides an alternative to traditional allopathic medicine which relies heavily on the use of petrochemical based pharmaceuticals. There has been a larae increase in interest in homeopathic medicine in the United States in recent years due, in larqe part, to a growing disenchantment with allopathic medications and the complications and side effects arising from their use. 22 8 5 9 3 PATENT 540270-2070 their optimum healthful level of operation; that is, their natural bioloaical "set points".

Throuqh our modern understandino of qenetics each bodilv member and process is seor. as the result of codes programmed into each individual cell. Homeopathic medicine seeks to utilize natural substances , particularly herbs, to naturally and oentlv induce the bodv to restore its equilibrium, tha*" is, for all function and processes to return to their set points. Homeopathic medicine looks upon illness and disease as being a state of disequilibrium from the body's optional set points. A fundamental precept of homeopathic medicine is that a smal] force or stimulating agent can produce disproportionally greater results, if optimallv and effectively applied. Thus, proper administration of a small quantity of a homeopathic medicine can have a large effect in restoring the body to its oroper state of equ5librium.

A further advantage of homeopathic medicaments is that they are relatively inexpensive as compared to traditional chemical-based pharmaceuticals. Another fundamental precept in the formulation of homeopathic pharmaceuticals is that repetitive dilution from an orioinal concentrate does not diminish efficacy of the formulation.

Thus, large quantities of homeopathic pharmaceuticals can be prepared from a relatively small amount of starting solution.

A traditional homeopathic procedure involves a 1 to 10 dilution. Each time the 1 to 10 dilution is repeated the resulting potency changes by one increment. The scale for such change is noted by the symbol "X". The first 1 to 10 dilution is named "IX", the fifth dilution is named "5X', and so on.

Further, the starting ingredients themselves are natural and relatively inexpensive. The formulation of solutions of homeopathic pharmaceuticals is also a relatively simple process.

In contrast, the manufacture of traditional chemical-based pharmaceuticals generally involves a complicated and costly chemical manufacturing process. Moreover, because the effectiveness of such traditional chemical-based pharmaceuticals resides in the potency of the formulation administered, dilution of the pharmaceutical to a lower potency results in reduced effectiveness. Generally, all such chemical-based pharmaceuticals must be formulated at or near the concentration level or potency at which they will ultimately be administered. Thus, in order to produce large quantities of a pharmaceutical, proportionately large manufacturing facilities are required, which only further adds to the expensiveness of the chemical-based pharmaceuticals utilized in classical allopathic medicine.

Another ancient and long accepted healing art is acupuncture which is believed to have originated in the Orient. Acupuncture involves the relief of symptoms and the cure of illness and injury by the controlled stimulation of points on the human body which regulate or interact with the functioning of specific organs or bodily members to which the acupuncture points are related. 22 8 5 9 3 PATENT 540270-2070 Modern science has tried to determine the mechanism by which acupuncture works. One proposed explanation is that stimulation of acupuncture points on the bodv causes the release of endorphins bv the body. Endorphins are natural substances released within the body which, among other functions, operate to desensitize neuroloaical pathways bv which pain is perceived. Bv relieving the pain associated with symptoms and with illness and injury, the body itself is then able to utilize its natural immune syst.en and the healing process to restore equilibrium and a normal healthful condition. Natural set points are restored and the affliction thereby eliminated. Pain acts as a warning indicator that something is wreno in the body. Py determining the source of the pain and the acupuncture pcints on the body to which the pain, is responsive, the pain cycle can be broken ar.c the natural healinq process induced. Stimulation through acupuncture, which typically involves the insertion of small needles into the acupuncture points on the bodv, causes p release of endorphins which block pain sensed over the neurological pathway's and enable other natural healinq mechanisms in the bodv to restore a condition of homeopathic equilibrium to the bodv by killino invar.ive pathogens, restoring chemical or hormonal imbalance, or forterino the mending of phvsically injured tissues, muscles and/or bones. Over the many years that acupuncture has been practiced, specific points on the 22 8 5 9 PATFNT 5-30?70-207C human body have been determined which reaulat-o thf ^unctionino of all bodily members and processes. Thus, the appropriate points for stimulation for anv given condition are known to skilled practitioners in the art.

One particular acupuncture treatment syster developed in Japan bv Dr. Voshio Manaka is based on a conception of the human body as encompassing two basic svstems, an energetic svsten and an informational system. The energetic system utilizes the greater portion of energy in the bodv. The informational svster controls the energetic system and responds to both external and internal stimuli.

Acupuncture is viewed as a therapeutic modality which interacts with and regulates the body's informational system. Dy influencing the informational system, large changes can be induced with minimal stimulation while allowinc? the body to function as naturally as possible while its processes are gradually restored to their equilibrium set points.

A recent development in methods of medical treatment has been the discovery of the therapeutic properties of magnetic and electro-magnetic fields and their use in the treatment of illness and injury. Modern science has demonstrated that al1 living beings exhibit an electromagnetic field about them. Homeopathic medicine teaches that illness and injury create disturbances to the body's natural electro-magnetic fields. The administration of therapeutic 22 8 5 9 3 PATENT 54027O-:C7O fields restores the bodv's natural fields to their equilibrium, levels. The therapeutic effects of the application of pulsed magnetic field.': in the treatment of traumatic injuries to limbs, muscles, tendons, bones and the like, as well as in the treatment of illness such as arthritis, is well-known in the art of medical science.

The human bodv's susceptibi1itv to magnetic fields is due in large part to the electrolvtic properties of raanv of the chemical constituents of the body. All electrolytic substances are capable of conducting an electric current and wherever sr. electric current is flowing, a magnetic field is created. The greater the electrolytic properties of the substance, the greater ir its conductivity and therefore the areater the resulting maor.etic field created during current f low.

The body generates a magnetic field of its own due partly to the presence of iron-carrvinq charged particles flowino in the blood stream. Other electrolvtic substances in the body such as potassium and sodium, in ionic form, are present in substantial amounts and contribute to the body's overall bioelectric/bionagnetic field. It is well known that blood cells are readilv polarized when placed in a magnetic field due to the high iron concentration in the blood. Under certain conditions, magnetic fields alter the orientation of blood cells and induce changes in the biological reactions in 22 8 5 9 3 PATENT <? o ? ? o -: o~ o which they participate, thereby incdifyinq the probability of chemical bond formation.

Human blood is very sliahtly alkaline with respect to bod;- cells which are more acidic. Maaret.ic fields can be used to induce reactions which restore the pH cf the blood.

For example, in a condition prompted by over-acidity of the blooc, that is, one characterised by a low pH, application of maanetic field enerav emanating from the north pole of a magnet, which, by convention, is considered to be negative, and which, homeopathically, is considered to be alkaline, helps to restore the blood to its normal pH level.

It has also been shown that the blood's leucocyte count is influenced by maonetic fields. The number of lencocvtes in the blood increases or decreases depending on prevailing magnetic field conditions.

Therapeutic treatment? utilizing magnetic energy operate to produce two curative effects. Therapeutic magnetic fields produce a treatment component which in the case of traumatic physical injury causes a reduction in swelling, a reduction of edema, a draining of fluid build-up due to inflammation and a desensitization to pain.

Therapeutic magnetic energy fields also produce a stimulating component which in the case of traumatic physical injury dilates blood vessels and increases blood circulation, 228593 PATENT 540270-2070 disperses fluid build-up due to inflammation, and strengthens and promotes the healinq of damaaed tissue.

The application of pulsed magnetic energy has been observed to cause transcutaneous electrical neural stimulation and contributes to the reduction of chronic pain by causing the release of natural pain relieving substances at the spinal cord level and by causing the release of endorphins and ACTH at the pituitary gland level.

As a result of research into the field? of homeopathic pharmaceutical medicine, acupuncture and biomagnetic therapy, a new modality of medical treatment has been developed which combines the features of all three of the above treatment methods in a noval way. Accordingly, a new and unique method of medical treatment has been discovered which is more efficacious than anv of the three methods described above.

OBJECTS OF THE INVENTION Accordingly, a primary object of the present invention is to disclose a new modality of medical therapy which utilizes aspects of homeopathic pharmaceutical therapy, acupuncture therapy and biomagnetic therapy, in combination.

A further object of the invention is to devise a full range of modes of administration of magnetically induced a a. H f i h g homeopathic remedies, including topical, injectable, auricular and oral forms.

A further object of the invention is to provide particular homeopathic pharmaceutical formulations for the treatment of specific illnesses, physical injuries and other chemical and hormonal disequilibrium conditions of the human body with precisely determined acupuncture sites to which the homeopathic pharmaceutical remedies are to be applied in the treatment of each specific condition.

A further object of the invention is to provide appropriate means for inducing the biomagnetic field in the homeopathic pharmaceutical remedy for each form of administration.

Summary of the Invention The present invention is directed to a method of treatment of human illness and injury by administering to the patient one or more chemical formulations such as homeopathic medicaments through selected acupuncture points stimulated by a controlled magnetic field. A very broad spectrum of human illnesses can be effectively treated by homeopathic medicaments of the instant invention through selection of the appropriate homeopathic remedy, preparation of a mixture of the homeopathic remedy and a magnetically permeable component and magnetization of the resulting mixture during administration to the patient through specific acupuncture sites. 22 8 5 9 PATENT 540270-2070 Various embodiments of the invention include administering therapeutic amounts of the magnetic mixture in oral, injectable, topical and auricular forms. Further, depending upon the condition being treated the dosage and frequency of administration will vary. In a particularly preferred embodiment the patient is administered with a regimen of both oral and injectable dosages.

BRIFF DESCRIPTION OF THE DRAWINGS Aspects of the present invention are illustrated by the accompanying drawings in which: Figures 1A and IB show two preferred embodiments of oral delivery vehicles for the administration of homeopathic medicaments; Figures 2A ar.c 2B show embodiments for the topical administration of a homeopathic medicament; Figure 3 shows a preferred embodiment for imparting a magnetic field to the injectable form homeopathic medicaments; and DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION The homeopathic medicaments of the present invention when administered through specific acupuncture sites have demonstrated remarkable efficacv in the treatment of a wide range of afflictions, many of which have no known cure in the realm of allopathic medicine. Effective delivery systems for 3.13 "3 <"13 these homeopathic formulations have been devised including topical, injectable, auricular and oral forms.

In accordance with the teaching of the present invention the homeopathic medicament, administered in whatever form is selected, must first be carefully mixed with an effective amount of a magnetically permeable ingredient. Although numerous compounds are suitable, it has been found that ferrous gluconate is particularly effective. The resulting mixture is then prepared for administration to the patient depending upon the specific delivery system used. During administration to the patient, the medicament is charged or influenced by a magnetic field which imparts a "unipolar magnetic charge" to the medicament as it enters the body through a pre-selected acupuncture point. The term "uni-polar magnetic charge" is used despite the magnetic force applied is bipolar since only one magnetic pole is available to influence the patient at the specific acupuncture point being used. The actual magnetic influence is therefore for all practical purposes unipolar. For example when the formulation is injected using a hypodermic needle device such as that to be described below the hypodermic needle is transformed into a magnet. The point of the needle has the opposite polarity to that of the hub section of the device and since only the point of the needle goes into the tissue and comes into direct contact with the body the magnetic influence is essentially unipolar. Such application of a magnetic charge at or in close proximity to the acupuncture site is believed to stimulate or activate the acupuncture site thereby enhancing the therapeutic efficacy of the medicament being administered. v -12- (followed by page^'12a) $ a.8 S°i 3 Effective results have been achieved when applying a magnetic charge of less than 10 gauss, particularly in the range of from 1 to 10 gauss, to the medicament as it is being administered through the acupuncture point. Such low levels of magnetic flux can aptly be described as homeopathic. It has further been found that the most effective acupuncture sites are located in the arms and legs below the elbow. ir'"*N 22 8 5 PATENT 540270-2070 knee, respectively. These points are commonlv referred to as the "command points" and are well known to those skilled in the art.

Having described the invention in its most fundamental terms, the various forms of administration of medicament will now be described in detail. Reference is made to the accompanying figures where appropriate.

One delivery svstem used is by injection. The formulation dosace and duration of treatment for the injectihle medicaments is described in detail in the formulation examples which follow. Since it has been observed that iniectinc homeopathic medicaments demonstrate unexpected and significantly enhanced efficacy when a unipolar magnetic charge is imparted to the medicament during administration or injection into an acupuncture point, a device has been developed to enable the administering physician to suitably charge the medicament. One such device is shown in Figure 3.

This device consists of a housing 10 containing an electromagnetic coil 12 positioned to impart a controlled magnetic charge to plate 14. A syringe or hypodermic needle 16 used to inject the homeopathic medicament can be positioned in housing 10 such that the point of the needle or syringe is in close proximity to plate 14 as shown in Figure 3.

Another alternative delivery system used is the topical. One particularly preferred topical is illustrated in 22 8 5 9 PATENT 540270-.? 070 Figure 2A. The topical patch 20 is made of a porous material such as sintered metal capable of absorbing a therapeutic amount of homeopathic medicament. The patch 20 has an extended opening therethrough in which is tightly fitted a metal rod or core 22 which can readily accept and retain a magnetic charge. Suitable materials include iron and nickel. The patch 20 can then be impregnated with a therapeutic amount of desired homeopathic medicament. A unipolar magnetic charge is then imparted to the metallic core 22 of patch 20 which is then affixed to a suitable acupuncture point.

One method for affixing the topical patch to the acupuncture point is to hold it in place with adhesive bandage, surgical tape or the like. For preparations that are to be affixed tc acupuncture points on the limbs, such as on the wrists, arms, ankles or legs, the magnetically influenced homeopathic medicament can be placed in a band which can be comfortably strapped afound the member at the desired location.

In certain alternative embodiments, the homeopathic pharmaceutical formulation can be magnetized in situ by placing a permanent magnet or other source of magnetic flux on top of the portion of the homeopathic mixture to be magnetically activated. 228593 PATENT 540270-2070 Still another form of a topical for administering homeopathic medicaments is a pellet or "button" as illustrated in Figure 2B. The butter. 30 can be stamped out under pressure in a process generally known as the sintered metal process. To fabricate the button, a 50/50 powdered mixture of Ni (nickel) and Fe (iron) is fed into a press mold. This composition inhibits corrosion ar.d readily accepts and holds a magnetic charge. Since the finished pellet or button is porous it can easily be impregnated like a sponge with a therapeutic homeopathic tincture. The button is then formed with pressure to the desired shape*.

A protrusion 32 on the underside of button 30 effectively increases the overall therapeutic effect of the topical bv providing direct physical stimulation of the acupuncture point. Although other shapes can certainly be used, the smooth domed top of button 30 is desirable as being less obtrusive on the surface of the skin. After the button 30 is formed and impregnated with medicament, it is magnetically charge so that the desired polarity is imparted to the under surface of the button which is affixed in place over a pre-seiected acupuncture point. One polarity is on the upper surface of the button (the domed surface awav from the skin) and the other pole is on the lower surface of the button in contact with the skin. 22 8 5 9 PATENT 540270-2070 Still another form of administering homeopathic medicaments is oralis by means of a pill or tablet. Two such oral tablets are shown in Figures 1A and IB.

With reference to Figure 1A, this oral device can aptly be described as a medicinal "lollipop" consisting of a rod portion 40 and a ball or bulbous portion 42. The rod 40 is made up of a metal such a? iron capable of holding a magnetic charge. The ball portion 42 has an inert core such as molded plastic, for example. The rod 40 is coated with a plastic or vinyl coating 44 extending to the ball portion 42. The bail portion 4 2 is coated with a homeopathic composition made of sugar and Ferrous aluconate mixed to a dilution in the ranqe of 3x to 4x. It is then impregnated with an alcohol tincture containing the desired homeopathic medicament.

The entire device can be encased in a sanitary wrapping. To use the "lollipop" the entire device in its wrapping if desired is first placed in a suitable electromagnetic field. In this way, all of the metallic elements of the device are magnetized with the ball portion being charged with one polarity and the rod portion with the opposite polarity. In this manner, the therapeutic portion of the device having a unipolar charge can then be placed under 228593 PATENT 540270-2C7G the tongue of the patient in order to contact the acupuncture points in the mouth.

Alternativly, a pill as shown in Figure IB can be used. The Dill 50 has a core 52 formed of a standard homeopathic sucar globule made in conventional manner. Dry Ferrous gluconate powder (UFP grade) is triturated with very fine sugar in a 1-9 proportion in a grinding machine to make a homeopathic dilution of 2X. A second dilution (designed as 3X) is made in the same 1-9 proportions using the 2X dilution and additional sugar. Succeeding dry dilutions are made in the same manner to a final dilution of 5X. The 5X dilution of the Ferrous gluconate and sugar is used to build inner layer 54 which surrounds the core 52. Layer 54 is built up by tumbling in a coatinc pan in arcordance with known methods for the manufacture of homeopathic remedies. Layer 54 is then covered with a coating 56 which is impermeable tc water and alcohol. Ferrous gluconate is added to coating 56 so that it will have the same magnetic permeability as layer 54 cor.taininc ferrous gluconate and sugar. An outer layer 58 is then built up around coating 56 in the same manner as inner layer 54 was formed. The thickness of outer layer 58 should be approximately twice that of inner layer 52 for optimum results and is similarly made of a Ferrous gluconate sugar mixture in 5X dilution. The pills are then thoroughly air 228593 PATENT 540 2 70-2070 dried. The diameter of the finished pill should preferably bo approximately one certimeter.

The layered pill made according to this procedure can then be medicaf.pd in conventional manner. For example, a measured weight of the finished, dried pill? is placed in a suitable container and a predetermined amount of the desired homeopathic medicinal tincture is added. The homeopathic tincture is of a dilution of 3CX which has been manufactured in accordance with traditional homeopathic procedure from herb? or other raw materials. The containers with the pills are then rotated ir a roller mill for approximately cne hour to permit the pills tc conpletely absorb the alcohol tincture. The pills are then transferred from the containers to paper covered trays where they are air dried Until no trace or odor of the alcohol remains. The pills are then individually packaged (a single pill to each container) in a vial-like tube with a threaded cap or tightly fitting friction lid. The cap is preferably larger in diameter than the vial so that it projects to form a rim around the vial at the top. Precautions should be taken during processing to avoid contamination or de-activation of the pills.

The medicated pills can then be administered to the patient. A vial containing the pills is placed into a suitable magnetic filed so that each pill is magnetized just prior to ingestion by the patient. The pill should be inserted 228593 PATENT 540T70-2070 directly into the mouth from the vial without handling. The patient can then suck on the pill to gradually dissolve it until the impermeable coatina is reached at which point the patient should discard the remainder of the pill.

Yet another form of administerina the homeopathic medicaments is by auricular measures. One such device consists of an earplug containina dosages of the homeopathic medicament which can be administered through holes in the earplug to the acupuncture points in the ear. The earplug device can be made by any number of means with the understanding that it must be able to ur.ccntrol lablv release medicament to predetermined auricular acupuncture points. This can best be accomplished by either using rods or small protrusions aligned with the acupuncture points and capable of releasing medicament. For best results, the homeopathic medicament is magnetized after it is deposited in the earplug device in accordance with the procedure described above for imparting a magnetic charge to the topical or oral forms of administration.

The following examples illustrate the embodiments of various aspects of the invention. The examples are provided to illustrate the scope of the invention and are not intended to be limiting. Other applications of aspects of the invention within its broad scope will be apparent to those skilled in the art. 228593 PATENT 540270-2070 FOPMUI.ATrON FXAMPLE5 A. INJECTABLE Example 1 An injectable dosage form of an herb-based homeopathic medicament designated FNG-11, for the treatment of fungus and yeast infections, having a homeopathic potency of 30X was prepared from an original concentrated tincture menstrum containinc extracts of the herbs Tecoma conspicua and Melaleuca alternifolia in ?9 + ? alcohol. The original concentrated tincture was then diluted to 30X potency (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance _4 in a homeopathic potency of £ x (10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage Dortions of 0 . 2cc volumes were set aside as needed depending upon the number of acupuncture points being used. The formulations injected were controllablv magnetized during administration through the acupuncture sites as described above.

Example 2 An injectable dosage form of an herb-based homeopathic medicament, designated HG-9 , for the treatment of intestinal parasites, particularly Giardia lamblia and Entamoeba histolytica, was prepared from an original 22 85 9 3 PATENT 540270-.? 070 concentrated tincture menstruum containing extracts of the herbs Osbeckia chinensis, Pulsatilla chinensis, Punica granatum, Acalpha australis, Cephaelis ipecacuanha, Picrasma ailanthoides, Asarum sieboldi, Brucea javanica, Magnolia officinalis, Artemvsia apiacea , and Dichroa febrifuga in 99 + 1? alcohol. The original concentrated tincture was then diluted to 30X potencv (10 ^ times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically - 4 permeable substance in a homeopathic potency of 4 X (10 ), was added to the dilute homeopathic solution in order for it tc hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0. 2cc volumes were set aside as needed. The formulations injected were controllablv magnetized during administration through the acupuncture sites as described above.

E>;annle 3 An injectable dosage form of an herb-based homeopathic medicament designated VR-27, for the treatment of broad spectrum viral infections, having a homeopathic potency of 30X was prepared from an original concentrated tincture .menstruum containing an extract of the herb Centella asiatica minor in 99 + ? alcohol. The original concentrated tincture was then diluted to 30X potency (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 ^), was added to the dilute homeopathic y«"S r 22 8 5 9 3 PATENT 540270-2070 solution in crder for it to hold a maonrMc charge when passed through a magnetic field. Injectable dosace portions of P . 2cc volumes were set aside as needed. The formulations injected were controllahly magnetised durinn adninistration throunh the acupuncture sites as described above.

Example 4 An injectable dosaqe form of an herb-based homeopathic medicament desinnated SPN-7, for the treatment of traumatic injury to muscles, tendons, ligaments, and for the treatment cf sprains, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Radix preudoginseng, Dryobalanops aromatica, Gynura segetum, and Moschus moschiferous in 99 + Q- alcohol. The original concentrated tincture was then diluted to 30X potency (10 ^ times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance -4 in a homeopathic potency of 4 x flO ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed throuch a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 5 2 2 8 5 P PATENT 540270-2070 An injectable dosaqe form of an herb-based homeopathic medicamert, designated TYR-in, for the treatment of hypothyroidism, was prepared from an original concentrated tincture menstruum containing ar extract of the herb Organ protomorphoqir in 99+% alcohol. The original concentrated tincture was then diluted to 30X potencv (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic - 4 potency of 4 x (10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosaae portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 6 An injectable dosage form of an herb-based homeopathic medicament, designated HRM-4, for the treatment of premenstrual syndrome, menopause, and reproductive hormonal imbalance, was prepared from an original concentrated tincture menstruum containing ar extract of the herb Angelica sinensis in 99x!l alcohol. The original concentrated tincture was then -30 . . ■ diluted to 30X potency (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance 22 8 5 9 PATENT 540270-2070 -4 in a homeoparhic potency of 4 x 10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 7 An injectable dosage form of a homeopathic medicament, designated FYT-12, for the treatment of hvdro- thvroidisir., was prepared frorr an original concentrated tincture menstruum containing a solution of aqueous iodine ir. 99Al alcohol. The original concentrated tincture was diluted to 30X potencv (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically -4 permeable substance in a homeopathic potency of 4 x (10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 8 22 8 5 9 3 PATENT 540270-2070 An injectable dosaqe form of an herb-based homeopathic medicament for the treatment of hypertension, designated RLX-22, was prepared from an original tincture menstruum containing extracts of the herbs Rock Rose, Clematis, Impatipr.s, Cherry Plum, and Star of Bethlehem in 99 + ^. alcohol. The original concentrated tincture was then diluted to 30X potency (10 times the oriqinai concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 -4 x '10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 9 An injectable dosage form of an herb-based homeopathic medicament, designated IMN-2, for restoring and strengthening the body's natural immune svstem, having a homeopathic potency of 30X was prepared from an oriainal concentrated tincture menstruum containing extracts of the herbs Astragalus membranaceous, Nux vomica, Panix ginseng, Germanium and extract of Thymus gland in 99+1 alcohol. The oriainal concentrated tincture was then diluted to 30X potency 22 8 5 9- PATENT 540270-2070 (in ^ tines the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance -4 in a hcrreopathic potency of 4 >: (10 ) , was added to the dilute homeopathic solution in order for it to hold a maanetic charge when passed through a magr.ctic field. Injectable dosage portion? of 0.2cc volumes werf set aside as needed. The foriru la t ions iniected were controllably magnetized during administration through the acupuncture sites as described above.

Example 10 Ar injectable dosage form of a homeopathic medicament for the treatment of hypoglycemia, designated HYG-6, was prepared from an oriainal concentrated tincture menstruum containing sulfur and glycerin ir 99+1 alcohol. The oriainal concentrated tincture was then diluted to 30X potency (10 times the original concertration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance -4 in a homeopathic potency of 4 x (10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a macnctic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 1J. - 26 12 8 5 9 7 PATENT 54 0270-2D 70 An ir.icct.able dosage form cf ar. herb-based homeopathic medicament, designated INF-16, for the treatment of bacterial infection?, particularly staff and strep, was prepared from an original concentrated tincture menstruum containina extracts of the herbs Senecia scandens, Scutellaria baicalensis, Magnolia officinalis, Lcnicera japor.ica, and Andrographis par.iculata in alcohol. The original concertrated tincture was then diluted to 3OX potency (10 ^ tines the oriainal concentration) with sterile isotonic saline. Ferrcus gluconate, a maar.etical lv permeable substance -4 in a homeopathic potenc" of 4 >: (10 ) , was ac.ded to the dilute homeopathic solution in order for it to hold a nacrnetic charge when passed through a magnetic field. Injectable dosaqe portions of G.7cc volumes were set aside as needed. The formulations injected were controllablv magnetized during administration throuah the acupuncture sites ftp described above .

Example 12 An injectable dosage form of ar herb-based homeopathic medicament, designated FLU-17, for the treatment of viral infections due to colds and influenza, particularly rhino-virus, was prepared from an original concentrated tincture menstruum containing extracts of the herbs Lonicera confusa, Chrysanthemum indicum, Vitex nequndo, Eucdia lepta, Ilex asprella, Menthol, and 22 8 5 9 3 PATENT 540270-2070 Baphicacanthus curia in 99+1 alcohol. The original concentrated tincture was then diluted to 30X potency (10 times rhf oriqinal concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance - <5 in a homeopathic potencv of & >: (10 ) , was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosaqe portions of 0. 2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 13 An injectable dosage form of an herb-based homeopathic medicament, designated AIL-5, for the treatment of hayfover and airborne allergies, was prepared from an-original concentrated tincture menstruum containina extracts of the herbs Gentiana luta, Citrus aurantium, Tanacetum vulgare, Chicus henedictus, Menyanthe? trifoliata, Grindelia robusta, and Ephedra sinica in 99+1 alcohol. The oriainal concentrated -30 tincture was then diluted to 30X potency (10 times the original concentration) with sterile isotonir saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic potency of 4 x (10 ^), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed 28 - 22 8 5 9 PATENT 540270-2070 through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized at the time of administratior. through the acupuncture sites as described above.

Example 14 An injectable dosage form of an herb-based homeopathic medicament, designated OPN-26, for the treatment of chronic muscular and joint pain, having a homeopathic potency of 5X was prepared from an original concentrated tincture menstruum containing an extract of the herb Rhus toxicodendron in 99x* alcohol. The original concentrated tincture was then diluted to 30X potency (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic - 4 potency of 4 x (10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnetized during administration through the acupuncture sites as described above.

Example 15 An injectable dosage form of a homeopathic medicament, designated SMK-30, for the treatment of nicotine addiction and the craving to smoke cigarettes, other nicotine containing tobacco products, and the like, having a 22 8 5 9 PATENT 540270-2070 homeopathic potency of 30X was prepared from an original concentrated tincture menstruum containinq an extract of cigarette smoke in 99+1 alcohol. The original concentrated tincture was then diluted to 30X potency (10 times the original concentration) with sterile isotonic saline. Ferrous gluconate, a magnetically permeable substance in a homeopathic - 4 potency of 4 x (10 ), was added to the dilute homeopathic solution in order for it to hold a magnetic charge when passed through a magnetic field. Injectable dosage portions of 0.2cc volumes were set aside as needed. The formulations injected were controllably magnptized during administration through the acupuncture sites as described above. 3. ORAL FORM Example 16 An oral dosage form of the herb-based homeopathic medicament FNG-11, prepared as set forth in Example 1 above, having a homeopathic potency of 30X was prepared in accordance with the procedure described above in connection with the pill illustrated in Figure IB.

Example 17 An oral dosage form of the herb-based homeopathic medicament HG-9, as in Example 2, having a homeopathic potency of 30X, was prepared according to the method of Example 16. Example 18 22 8 5 9 3 PATENT 540270-2070 An oral dosage form of the herb-based homeopathic medicament VR-27, as in Example 3, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example 1? An oral dosage form of the herb-based homeopathic medicament SPN-7, as ir. Example 4, having a homeopathic potency of 30X, was prepared accordinc to the method of Example 16.

Example 20 An oral dosage form of the homeopathic medicament TYR-10, as in Example 5, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example 21 An oral dosage form of the herb-based homeopathic medicament HRM-4, as in Example 6, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example 22 An oral dosage form of the homeopathic medicament TYR-12, as in Example 7, having a horneopathic potency of 30X, was prepared according to the method of Example 16.

Example 23 An oral dosage form of the herb-based homeopathic medicament RLX-22, as in Example 8, having a homeopathic 22 85 9 PATENT 540270-70 potency of 30X, was prepared according to the method of Example 16.

Example 24 An oral dosage form of the herb-based homeopathic medicament IMM-2, as in Example 9, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example 25 An oral dosage form of the herb-based homeopathic medicament HYG-6 , as in Example 10, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example ?6 An oral dosage form of the herb-based homeopathic medicament INF-16, as in Example 11, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example 27 An oral dosage form of the herb-based homeopathic medicament GLG-17, as in Example 12, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example 2 8 An oral dosage form of the herb-based homeopathic medicament ALL-5, as in Example 13, having a homeopathic 22 8 5 9 3 PATENT 540270-20 70 potency of 30X, was prepared according to the method of Example 16.

Example 29 An oral dosaae form of the herh-based homeopathic medicament OPN-26, as in Example 14, having a homeopathic potency of 30X, was prepared according to the method of Example 16.

Example 30 An oral dosage form of an herb-baspd homeopathic medicament, designated GU-14, fcr the treatment of gastric discomfort, borborvgmi, and flatus, havina a homeopathic potenr^ of 30X, was prepared according to the method of Example 16, where the original concentrated tincture menstruum contained extracts of the herb Coryandrus sativa.

Clinical Examples Example 31 A combined treatment regimen utilizing both the injectable and oral dosaqe forms of the FNG-11 homeopathic medicament (prepared according to Examples 1 and 16, respectively), was used in the treatment of a 44 year old female patient. Prior to treatment the patient exhibited symptoms including mood swings, premenstrual syndrome (P.M.S.), and fatigue, and was diagnosed as a result of 22 8 5 9 3 PATENT 5*0270-2070 visible yeast in a live cell analysis as suffering fror candidiasis. The injectable form dosage of FNG-11 was administered two times per week during the first week and once per week thereafter bilaterally to the two SP-6 acupuncture points. Duration of treatment by the iniectahle mode was for a total period of four weeks. Oral dosage forms were administered at an initial dosage rate of 3 tablets taken 5 times per day during the first week of treatment, reduced to 3 times per day curing the second week of treatment and finally to .? times per day for the balance of the duration of the treatment. The total duration of treatment under the oral form was for a period of 4 weeks. As a result of the above treatments, the patient's blood level yeast decreased by 60*. The patient's P.M.S. and other symptoms were controlled. Example 32 A combined treatment regimen utilizing bcth the injectable and oral dosage forms of the vn-27 homeopathic medicament (prepared according to Examples 3 and 18, respectively), was used in the treatment of a 41 year old male exhibiting symptoms including a history of prostatitis and gonorrhea with active leisons approximately 60-70% of the 22 8 5 9 3 PATENT 540270-2070 time. The patient was diagnosed as being infected with herpes simplex 2. The injectable form dosage of the VR-27 was administered two times per week during the first week and once per week thereafter bilaterally to the two TW-5 acupuncture points and the oral form dosaqe was administered initially at a rate of 3 tablets taken 5 tines per dav durir.c the first week of treatment, reduced to 3 times per day during the second week treatment and finally to 2 times per day for the balance of the duration of the treatment. Both the injectable ard era] forr dosages werr administered for a tota] treatment period of 6 weeks. After 3 weeks of treatment, the patient's condition improved to the extent that there were no active lesions and no further outbreaks of genital herpes. Example 3 3 A combined treatment regimen of oral and injectable forms of VR-27 was utilised in the treatment of a 33 year old female cf slender build and qood muscle structure. The patient exhibited classic ?vmptoms of Chronic Epstein-Barr Virus including chronic fatique, unrefreshed sleep, dark circles under the eyes, headaches, burning eves, hypersensitivity to briqht liqhts and smoke, non-specific muscle aches in shifting locales, lack of coordination, lack of balance, and persistent bouts of depressions that sometimes reached profound levels. She was uncertain of exact dates but 22859 PATENT 540270-2070 felt that she had had most of these symptoms for several years.

A blood test verified the diaqnosis of Epstein-Barr Virus. The E-B Virus antibody virus titer (VCA) was positive at 1:5170.

The patient was treated on a weekly basis with the homeopathic medicament by taking 3 oral tables t.i.d. The injectable form of VP-27 was injected through the TW-5 acupuncture point. Treatment continued for a period of approximately 2 months. At the end of this time the follow-up blood work showed that the sane anti-body titer had fallen to a level of 1:320; well below the critical point and within the range considered normal. The clinical signs and symptoms confirmed the lab work and the patient reported virtual freedom from the previous physical and emotional problems. She continued to be free of symptoms 18 months later.

Example 3* A female patient 36 years old, who was slightly overweight exhibited symptoms of constant vaginal infections with associated burninq, itching and discharge. She complained of extremely low energy level and felt that she was in a state of unremitting depression. Frequent attacks of acute diarrhea after food intake were accompanied by headaches and nausea. She feels much of her weight problem is water retention (abdominal bloatingl and reports a large number of t 22 85 9 PATENT 540270-2070 various food allergies. Relatively the same roster of complaints have been present in various combination for a period that, she estimates, could be as long as twelve years. The patiert diagnosed as suffering from chronic Candida albicans. Initial laboratory tests disclosed the following levels: IaG - 136 (normal max 100) IgA - 214 (normal max 1001 7qt-' - 143 (normal max 10C) The patient was treated with FNG-11 in injectable form introduced into acupuncture point SP-6 on a once a week basir- in addition to oral tablets of the same medication for 8 weeks. Followir.c treatrent laboratory tests disclosed the following leve1f: IgG - 51 IgA - 9 6 IqM - 99 The patient also reported a total cessation of the initiating and chronic symptoms complained of and has been fully comfortable with no recurrence since.

Claims (44)

WHAT WE CLAIM IS:

1. A process for preparing a chemical formulation for treating pathogenic conditions of the human body when the chemical formulation is administered through one or more specific acupuncture points of the body which are associated with producing a desired response to a particular condition being treated, comprising the steps of: preparing a mixture of at least one herb, herbal extract or other compound having therapeutic properties to which a particular condition being treated is responsive; adding a magnetically permeable substance to the mixture; and magnetizing the resulting mixture in a magnetic field to impart a substantially "unipolar magnetic charge" (as herein defined on page, 12) on said mixture.

2. The process of claim 1 wherein the formulation is magnetized in a magnetic field of from one to ten gauss.

3. The process of claim 1 or 2 wherein the formulation is suitable for topical administration.

4. The process of claim 1 or 2 wherein the formulation is suitable for administration by injection.

5. The process of claim 1 or 2 wherein the formulation is suitable for auricular administration.

6. The process of claim 1 or 2 wherein the formulation is suitable for oral administration.

7. The process of claim 3 wherein the formulation is suitable for administering a therapeutic amount over at least one of said acupuncture points on the surface of the body. -38-

8. The process of claim 4 wherein the formulation is suitable for injecting a therapeutic amount into at least one of said acupuncture points.

9. The process of claim 5 wherein the formulation is suitable for administering a therapeutic amount in receptacles in a device for insertion into the auricular meatus, the receptacles being located in said device such that the formulation is in contact with at least one auricular acupuncture point when the device is inserted in the auricular meatus.

10. The process of claim 6 comprising forming a therapeutic amount of the formulation into a pill having an inert sugar-based core surrounded by a first layer comprised of a mixture of sugar and a magnetically permeable compound, said first layer being coated with a magnetically permeable layer which is impermeable to water and alcohol, and said layer being surrounded by a second layer of substantially the same composition as the first layer and approximately twice the diameter.

11. The process of claim 6 wherein the formulation is prepared for administering a therapeutic amount to acupuncture points in the mouth by means of an oral delivery device which is magnetically transparent and permeable comprising a rod portion connected to a ball wherein said rod portion has a core capable of accepting and holding a magnetic charge and is covered by a plastics or vinyl coating extending to the ball portion which is impregnated with the therapeutic amount of said formulation.

12. The process of claim 1 or 2 wherein the mixture of at least one herb having therapeutic properties and a magnetically permeable substance is magnetized by placing a source of magnetic flux in proximity to the mixture while it is placed over one or more acupuncture points on the surface of the body.

13. The process of claim 1 wherein an oral form and an injectable form of the chemical formulation are prepared for the purpose of being administered through two or more specific acupuncture points, the process comprising dissolving a solute of one or more therapeutic herbs or herbal extracts or other compounds having properties to which the particular condition being treated is responsive in a solvent, wherein the solvent for the oral formulation is a mixture of at least 99% by weight of alcohol, and the solvent for the injectable formulation is a mixture of at least 99% by weight of alcohol diluted with sterile isotonic saline; adding a magnetically permeable, non-toxic substance to each formulation; magnetizing each resulting formulation in a magnetic field to impart a substantially "unipolar magnetic charge" (as herein defined on page 12) on each formulation; and impregnating the oral formulation into a solid to be placed in the mouth to release the magnetized mixture contained therein to stimulate acupuncture points in the mouth.

14. The process of claim 13 wherein the condition being treated is a traumatic injury to one or more joints, muscles, tendons and ligaments and the solute of the magnetized solution comprises an effective amount of one or more herbs or herbal extracts selected from the group consisting of Radix pseudoqinsenq. Drvobalanops aromatica, Gvnura seqetum and Moschus moschi ferous .

15. The process of claim 14 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30x, for administration to the initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment. -40-

16. The process of claim 13 wherein the condition being treated is hypothyroidism and the solute of the magnetized solution comprises an extract of thyroid organ protomorphogin.

17. The process of claim 14 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, for administration bilaterally to each of two LI-11 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.

18. The process of claim 13 wherein the condition being treated is one or more of pre-menstrual syndrome, menopause and reproductive hormonal imbalance in female human beings and the solute of the magnetized solution comprises the herb Angelica sinensis or an extract thereof.

19. The process of claim 16 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment, and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 3 0X, for administration bilaterally to each of two SP-6 acupuncture points, and for administration initially from once or twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.

20. The process of claim 13 wherein the condition being treated is emotional depressions and/or hypertension, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Rock Rose, Clematis. Impatiens. Cherry Plum and Star of Bethlehem. ass 5^3

21. The process of claim 18 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, for administration bilaterally to one pair of the HE-5, HE-6 or HE-7 acupuncture points either once or twice.

22. The process of claim 13 wherein the condition being treated is a reduction in the body's natural immune system and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Anthemis nobilis, Smilax officinalis, Angelica officinalis, Medicaqo sativa, Rhamnus purschiana, Apium graveolens, Astragalus membranaceous. Taraxacum officinale. Gentiana lutea. Marrubium vulgare. Glvcvrrhiza glabra, Passiflora incarnata. Serenoa serrulata, and Polyqala senega.

23. The process of claim 20 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 3OX, for administration bilaterally to each pair of LI-11, SP-6, HE-5, HE-6 and HE-7 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.

24. The process of claim 13 wherein the condition being treated is hypoglycemia and the solute of the magnetized solution comprises a mixture of sulfur and glycerin.

25. The process of claim 22 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for -i administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, for administration bilaterally to each of two ST-36 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.

26. The process of claim 13 wherein the condition being treated is a general or localized bacterial infection of the body and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Senecia scandens, Scutellaria baicalensis, Magnolia officinalis. Lonicera iaponica. and Andrographis paniculata.

27. The process of claim 24 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times per day, reduced to two times a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, for administration bilaterally to each of two LI-11 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.

28. The process of claim 13 wherein the condition being treated is a general virus infection of the body and the solute of the magnetized solution comprises the herb Centella asiatica minor or an extract thereof.

29. The process of claim 26 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a -43- day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of from 5X to 30X, for administration bilaterally to each of the two TW-5 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.

30. The process of claim 13 wherein the condition being treated is a cold caused by the rhino-virus or influenza and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Lonicera confusa. Chrysanthemum indicum, Vitex nequndo. Eucdia lepta, Ilex asprella, Menthol, and Baphicacanthus cusia.

31. The process of claim 28 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 5X, for administration bilaterally to each of two TW-5 acupuncture points, and for administration initially once or twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.

32. The process of claim 13 wherein the condition being treated is one or more of hay fever and airborne allergies caused by pollens or spores, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Gentiana luta. Citrus aurantium. Tanacetum vulqare, Chicus benedictus, Menvanthes trifoliata. Grindelia robusta, and Ephedra sinica. -44- J&*.;SaSGc13;

33. The process of claim 30, wherein the oral formulation is a tablet having a homeopathic potency of 5X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, for administration bilaterally to each of two SP-9 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.;

34. The process of claim 13 wherein the condition being treated is one or more of local and systemic fungus and yeast infections, and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Tecoma conspicua and Melaleuca alternifolia.;

35. The process of claim 32 wherein the oral formulation is a tablet having homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 3QX, for administration bilaterally to each of two SP-6 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.;

36. The process of claim 13 wherein the condition being treated is infestation with intestinal parasites and the solute of the magnetized solution comprises one or more herbs or herbal extracts selected from the group consisting of Osbeckia chinensis. Pulsatilla chinensis. Punica qranatum, Acalpha australis. Cephaelis ipecacuanha. Picrasma ailanthoides, Asarum sieboldi. Brucea iavanica. Magnolia officinalis, Artemisia apiacea, and Dichroa febrifuga.;

37 . The process of claim 34 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, for administration bilaterally to both pairs of ST-36 and ST-37 acupuncture points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.;

38. The process of claim 13 wherein the condition being treated is chronic muscular and joint pain and the solute of the magnetized solution comprises the herb Rhus toxicodendron or an extract thereof.;

39. The process of claim 36 wherein the oral formulation is a tablet having a homeopathic potency of 30X, for administration initially as 2 tablets three times a day, reduced to twice a day and finally to once a day over the course of treatment; and wherein the injectable formulation is an injection of 0.2 cc per acupuncture point of the injectable solution having a homeopathic potency of 30X, for administration to the trigger acupuncture points relating to the members where pain is experienced and to specific pain points, and for administration initially twice a week for the first week of treatment and once a week on successive weeks over the course of treatment.;

40. The process of claim 1 wherein the condition being;Viyi.r treated is at least one of gastric discomfort, borborygmi and flatus in human beings; wherein an oral formulation is prepared with a therapeutic amount of a magnetized solution containing as a solute the herb Corvandius sativa or an extract thereof and as a solvent a mixture of at least 99% by weight of alcohol, diluted with ethanol, together with a magnetically permeable, non-toxic substance; further wherein the oral;-46-;0 2 B 5 S ?;formulation is a milk-sugar tablet carrier impregnated with the oral form solution; the tablet having a homeopathic potency of 5X and is prepared to dissolve in the mouth to coat the acupuncture points in the mucous membrane of the mouth with the solution.;

41. The process of claim 38, wherein the formulation comprises 3 tablets prepared to be administered as frequently as necessary until palliative relief of symptoms is experienced.;

42. The process of claim 1 wherein the condition being treated is nicotine addiction and the craving to smoke cigarettes and other nicotine containing tobacco products in human beings; wherein an injectable formulation is prepared with a therapeutic amount of a magnetized solution containing as a solute cigarette smoke or an extract thereof and as a solvent a mixture of at least 99% by weight of alcohol diluted with sterile isotonic saline, together with a magnetically permeable, non-toxic substance; the injectable solution having a homeopathic potency of 30X, and prepared to be injected in an amount of 0.2 cc per acupuncture point, bilaterally at two acupuncture points of the body.;

43. The process of claim 42 wherein the injectable magnetized solution is prepared to be injected on a one-time only basis.;

44. The process of preparing a chemical formulation, for treating pathogenic conditions of the human body, substantially as herein described in the formulation examples.;WEST-WALKER, McCABE;ATTORNEYS. KGR THE APPLICANT,;-47-*